Dr. Reddy’s Assures It Will Manufacture And Export Ozempic-Like Drug Without Selling In India In Novo Nordisk's Suit: Delhi High Court
On May 29, 2025, the Delhi High Court recorded an undertaking by Dr. Reddy’s Laboratories Ltd. that it will not sell its Semaglutide-based formulation—a drug similar to Ozempic—in India, amid an ongoing patent infringement suit filed by Novo Nordisk A/S. This statement was made during the hearing of a suit concerning the violation of Novo Nordisk’s patent rights under the Patents Act, 1970. Manufacture but no sale licence yet Senior…
